Circulating Biomarkers in Young Individuals with Low Peak FEV1
It is now well established that there is a range of lung function tralectories throughout the life course (1, 2). Specifically, 4-12% of young adults in the general population never achieve normal peak lung function, as determined by FEV, measurement (3). These individuals are at higher risk of developing chronic obstructive pulmonary disease (COPD) in adulthood (4), suffer a higher prevalence and a decade earlier incidence of cardiovascular and metabolic disorders, and die prematurely (3, 5). The biological mechanisms underlying these observations are unknown.
Autores: Nuria Olvera 1,2, Sandra Casas 1,2, Judith M. Vonk 3,4, Tamara Garcia 1,2, H. Marike Boezen 3,4, Maarten van den Berge 4, Alvar Agusti 1,2,5,6, and Rosa Faner 1,2,5*
Puedes leer el artículo completo aquí: https://www.atsjournals.org/doi/abs/10.1164/rccm.202205-0855LE?role=tab
Noticias relacionadas
Telomere length in patients with bronchiectasis
This study investigates telomere length (TL) in bronchiectasis patients, comparing them to COPD patients and healthy controls. Findings show no significant TL reduction in bronchiectasis compared to controls, but a trend towards shorter TL in idiopathic cases. Further research is needed to understand TL’s role in bronchiectasis.
Monitoring and assessment of CO2 and NO2 in schools within the Sentinel Schools Network of Catalonia during the COVID-19 era
Explore how the COVID-19 Sentinel Schools Network of Catalonia monitored CO2 and NO2 levels in classrooms, revealing key findings on ventilation and air quality in schools across Catalonia during the pandemic.
Physical activity and body mass related to catch-up lung function growth in childhood: a population-based accelerated cohort study
A study that identifies four lung function trajectories in children, highlighting that physical activity and BMI at 4 years predict catch-up lung function growth, particularly zFEV1, but not zFVC.
Más artículos
COPD
- 759578·Alberto Papi et Al.-Relationships between symptoms and lung function in asthma and/or chronic obstructive pulmonary disease in a real-life setting: the NOVEL observational longiTudinal studY
- 759785·Richard Beasley et Al – Prevalence, Diagnostic Utility and Associated Characteristics of Bronchodilator Responsiveness
- 759788·Alvar Agustí, Rod Hughes, Eleni Rapsomaki, Barry Make, Ricardo Del Olmo, Alberto Papi, David Price, Laura Benton, Stefan Franzen, Jørgen Vestbo, Hana Mullerova – The many faces of COPD in real life: a longitudinal analysis of the NOVELTY cohort
- 759883·Alberto Papi, Rosa Faner, Ian Pavord, Federico Baraldi, Vanessa M McDonald, Mike Thomas, Marc Miravitlles, Nicholas Roche, Alvar Agustí. – From treatable traits to GETomics in airway disease: moving towards clinical practice
- 768799·Surya P Bhatt Richard Casaburi Alvar Agusti et Al. Chronic obstructive pulmonary disease: hiding in plain sight, a Statement from the COPD Foundation Medical and Scientific Advisory Committee
Recuerda que puedes acceder a varios enlaces a artículos dentro de la categoría EPOC en esta web. También puedes acceder otros enlaces en el Listado de Artículos de la Cátedra de Salud Respiratoria.
Imagen obtenida en Canva Pro el 21 de junio de 2023
